doxazosin has been researched along with Hyperplasia in 1 studies
Doxazosin: A prazosin-related compound that is a selective alpha-1-adrenergic blocker.
doxazosin : A member of the class of quinazolines that is quinazoline substituted by an amino group at position 4, methoxy groups at positions 6 and 7 and a piperazin-1-yl group at position 2 which in turn is substituted by a 2,3-dihydro-1,4-benzodioxin-2-ylcarbonyl group at position 4. An antihypertensive agent, it is used in the treatment of high blood pressure.
Hyperplasia: An increase in the number of cells in a tissue or organ without tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vashisht, R | 1 |
| Sian, M | 1 |
| Franks, PJ | 1 |
| O'Malley, MK | 1 |
1 other study available for doxazosin and Hyperplasia
| Article | Year |
|---|---|
Long-term reduction of intimal hyperplasia by the selective alpha-1 adrenergic antagonist doxazosin.
Topics: Animals; Aorta, Abdominal; Catheterization; Dose-Response Relationship, Drug; Doxazosin; Female; Hyp | 1992 |